Abstract:The revascularisation process of transplanted human normal, hyperplastic and adenomatous parathyroid tissue was analysed at 2 and 4 days and 1, 2, 4, 7 and 12 weeks after transplantation to athymic mice. The transplants were examined by light and electron microscopy, immunohistochemistry and autoradiography. Vessels were detected by monoclonal antibodies specific for mouse and human endothelial cells. Immunohistochemistry demonstrated ingrowth of vessels from the host into the transplant and at one week numero… Show more
“…Fresh human PT tissue has proven functional when transplanted subcutaneously into athymic 238 mice (3,4). We have in these previous studies found a high take ratio, preserved morphology and a high area fraction of viable xenotransplanted normal, hyperplastic and adenomatous PT tissue, and we have further observed that adenomatous PT tissue had the highest proliferation rate and that transplanted PT tissue secretes human PTH (3).…”
Section: Discussionsupporting
confidence: 51%
“…It was, however, also found that the transplants showed varying degrees of cell disintegration (3). Capillary sprouting into the periphery of the transplants was observed during the first week, but only at 4 to 7 weeks were mature capillaries noticed (4). Despite this, measurable amounts of PTH from the transplants were observed at one week after transplantation.…”
mentioning
confidence: 97%
“…In a previous study, parathyroid hormone (PTH) secretion showed an increase during the first 7 weeks after transplantation of human PT tissue to athymic mice. Simultaneously, parenchymal cells multi-plyed and transplants were neovascularised by proliferating and migrating endothelial cells (3,4). It was, however, also found that the transplants showed varying degrees of cell disintegration (3).…”
Parathyroid hormone (PTH) mRNA in original and transplanted human adenomatous parathyroid tissue and human serum intact PTH (S-iPTH) was measured in athymic mice at 4, 7, 14, and 28 days after transplantation. Parathyroid tissue was obtained during surgery for hyperparathyroidism and implanted subcutaneously. PTH mRNA detection was done with RT-PCR followed by membrane blot and hybridisation and S-iPTH was analysed using a human specific immunoradiometric method. At 4 days, PTH mRNA was 79.6+/-5.3% (mean+/-SE) of that in original tissue whereas S-iPTH was only 5.4 ng/l. At 28 days, PTH mRNA was significantly reduced to 60.7+/-4.1% whereas S-iPTH was increased to 192 ng/l. The reduced PTH mRNA expression in the transplants at 28 days may be explained by an inhibited DNA transcription. The presence of human S-iPTH in transplanted mice at 4 days may be due to cell disintegration and diffusion. The gradual increase in S-iPTH during the experimental period probably reflects increased transplant cell volume and improved graft revascularisation.
“…Fresh human PT tissue has proven functional when transplanted subcutaneously into athymic 238 mice (3,4). We have in these previous studies found a high take ratio, preserved morphology and a high area fraction of viable xenotransplanted normal, hyperplastic and adenomatous PT tissue, and we have further observed that adenomatous PT tissue had the highest proliferation rate and that transplanted PT tissue secretes human PTH (3).…”
Section: Discussionsupporting
confidence: 51%
“…It was, however, also found that the transplants showed varying degrees of cell disintegration (3). Capillary sprouting into the periphery of the transplants was observed during the first week, but only at 4 to 7 weeks were mature capillaries noticed (4). Despite this, measurable amounts of PTH from the transplants were observed at one week after transplantation.…”
mentioning
confidence: 97%
“…In a previous study, parathyroid hormone (PTH) secretion showed an increase during the first 7 weeks after transplantation of human PT tissue to athymic mice. Simultaneously, parenchymal cells multi-plyed and transplants were neovascularised by proliferating and migrating endothelial cells (3,4). It was, however, also found that the transplants showed varying degrees of cell disintegration (3).…”
Parathyroid hormone (PTH) mRNA in original and transplanted human adenomatous parathyroid tissue and human serum intact PTH (S-iPTH) was measured in athymic mice at 4, 7, 14, and 28 days after transplantation. Parathyroid tissue was obtained during surgery for hyperparathyroidism and implanted subcutaneously. PTH mRNA detection was done with RT-PCR followed by membrane blot and hybridisation and S-iPTH was analysed using a human specific immunoradiometric method. At 4 days, PTH mRNA was 79.6+/-5.3% (mean+/-SE) of that in original tissue whereas S-iPTH was only 5.4 ng/l. At 28 days, PTH mRNA was significantly reduced to 60.7+/-4.1% whereas S-iPTH was increased to 192 ng/l. The reduced PTH mRNA expression in the transplants at 28 days may be explained by an inhibited DNA transcription. The presence of human S-iPTH in transplanted mice at 4 days may be due to cell disintegration and diffusion. The gradual increase in S-iPTH during the experimental period probably reflects increased transplant cell volume and improved graft revascularisation.
“…These findings indicate that it is even mandatory to simultaneously assay angiogenesis and endocrine function to really address transplant-induced, and thus specific, angiogenic activity. Ander et al (8) studied in detail early angiogenesis of human parathyroid tissue transplanted into nude mice. With species-specific antibodies, mouse-human microvessel chimeras were histologically detectable in the first week.…”
Section: Angiogenesis Of Parathyroid Transplantsmentioning
confidence: 99%
“…Likewise, parathyroid tissue can induce angiogenesis in vitro (6) and in vivo (7). Angiogenic activity was observed during the first week after transplantation (8). Moreover, it was shown that transplanted parathyroid tissue is capable of spontaneous reinnervation along newly built blood vessels after 1 week (9).…”
This model may serve to understand mechanisms associated with specific parathyroid transplant angiogenesis and its significance for transplant function to optimize clinical success of autotransplantation in therapy-resistant patients.
In athymic mice we have developed a model of long-term human PTH hypersecretion, using xenotransplantation of respectively parathyroid gland fragments obtained from patients with primary (primary) or secondary (secondary) uremic hyperparathyroidism (HPT), and parathyroid cells maintained in culture from patients with secondary uremic HPT. Both grafted parathyroid tissue fragments and cultured cells induced prolonged and marked secretion of human intact PTH (iPTH) in nude mice. Despite extremely high plasma iPTH levels, hypercalcemia or hypophosphatemia was not observed. Moreover, PTH secretion was not significantly modified by low-calcium, high-phosphate diet for 3 weeks. Four mice which had a mean plasma human iPTH level of 237+/-152 pg/ml for more than 9 months and 4 age-matched, sham-grafted control mice with undetectable human iPTH levels underwent bone histomorphometry examination. No difference was found between the two groups with respect to active bone resorption surface or number of osteoclasts/mm2. We hypothesize that the characteristic deficit of T cell function and of cytokine and growth factor production may protect nude mice with chronic hypersecretion of human PTH from hypercalcemia and bone lesions. We suggest that this strain of mice could be used for better understanding the relationship between cytokines and bone turnover.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.